Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
MapLight Therapeutics, Inc. (MPLT) had Stock-Based Compensation of $0.48M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-29.42M |
|
-- |
|
-- |
|
$31.50M |
|
$-31.50M |
|
$2.08M |
|
$-29.42M |
|
$-29.42M |
|
$-29.42M |
|
$-29.42M |
|
$-29.42M |
|
$-29.42M |
|
$-31.50M |
|
$-31.50M |
|
0.79M |
|
0.79M |
|
$-37.18 |
|
$-37.18 |
|
| Balance Sheet Financials | |
$245.31M |
|
$0.86M |
|
$11.92M |
|
$257.22M |
|
$18.56M |
|
-- |
|
$5.14M |
|
$23.71M |
|
$-274.18M |
|
$233.52M |
|
$233.52M |
|
0.81M |
|
| Cash Flow Statement Financials | |
$-91.31M |
|
$-80.65M |
|
$197.85M |
|
$38.46M |
|
$64.35M |
|
$25.89M |
|
|
Stock-Based Compensation |
$0.48M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-91.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
10.73% |
|
-12.60% |
|
-11.44% |
|
-12.60% |
|
$289.00 |
|
$-115.54 |
|
$-115.42 |
|